As of 2025-09-13, the Relative Valuation of Olema Pharmaceuticals Inc (OLMA) is (74.75) USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.00 USD, the upside of Olema Pharmaceuticals Inc based on Relative Valuation is -1034.4%.
The range of the Relative Valuation is (63.36) - (74.16) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.2x - 23.8x | 23.0x |
| Forward P/E multiples | 20.3x - 27.2x | 24.9x |
| Fair Price | (63.36) - (74.16) | (74.75) |
| Upside | -892.0% - -1027.0% | -1034.4% |
| Date | P/E |
| 2025-09-11 | -2.56 |
| 2025-09-10 | -2.50 |
| 2025-09-09 | -2.38 |
| 2025-09-08 | -2.43 |
| 2025-09-05 | -2.66 |
| 2025-09-04 | -2.03 |
| 2025-09-03 | -2.02 |
| 2025-09-02 | -2.07 |
| 2025-08-29 | -1.75 |
| 2025-08-28 | -1.77 |
| 2025-08-27 | -1.84 |
| 2025-08-26 | -1.84 |
| 2025-08-25 | -1.79 |
| 2025-08-22 | -1.85 |
| 2025-08-21 | -1.78 |
| 2025-08-20 | -1.75 |
| 2025-08-19 | -1.74 |
| 2025-08-18 | -1.85 |
| 2025-08-15 | -1.77 |
| 2025-08-14 | -1.69 |
| 2025-08-13 | -1.69 |
| 2025-08-12 | -1.70 |
| 2025-08-11 | -1.46 |
| 2025-08-08 | -1.49 |
| 2025-08-07 | -1.51 |
| 2025-08-06 | -1.60 |
| 2025-08-05 | -1.72 |
| 2025-08-04 | -1.73 |
| 2025-08-01 | -1.71 |
| 2025-07-31 | -1.65 |
| 2025-07-30 | -1.63 |
| 2025-07-29 | -1.61 |
| 2025-07-28 | -1.55 |
| 2025-07-25 | -1.51 |
| 2025-07-24 | -1.46 |
| 2025-07-23 | -1.49 |
| 2025-07-22 | -1.45 |
| 2025-07-21 | -1.47 |
| 2025-07-18 | -1.41 |
| 2025-07-17 | -1.44 |
| 2025-07-16 | -1.46 |
| 2025-07-15 | -1.47 |
| 2025-07-14 | -1.55 |
| 2025-07-11 | -1.49 |
| 2025-07-10 | -1.55 |
| 2025-07-09 | -1.60 |
| 2025-07-08 | -1.48 |
| 2025-07-07 | -1.43 |
| 2025-07-03 | -1.46 |
| 2025-07-02 | -1.45 |